Dr. Mobley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6445 Main St
# Opc
Houston, TX 77030Phone+1 713-441-5451Fax+1 713-791-5277
Education & Training
- University of MichiganFellowship, Surgical Critical Care, 2010 - 2011
- University of MichiganResidency, Surgery, 2003 - 2010
- Vanderbilt University School of MedicineClass of 2003
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Transplant Hepatology
Certifications & Licensure
- TX State Medical License 2014 - 2025
- CA State Medical License 2011 - 2024
- MI State Medical License 2009 - 2019
- American Board of Surgery Surgery
- American Board of Surgery Surgical Critical Care
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes Start of enrollment: 2022 Mar 11
Publications & Presentations
PubMed
- Transplantation for Peri-Hilar and Intrahepatic Cholangiocarcinoma With mTOR Immunosuppression.Samar Semaan, Ashton A Connor, Ashish Saharia, Sudha Kodali, Ahmed Elaileh
Transplantation Proceedings. 2025-03-01 - Neoadjuvant Multiagent Systemic Therapy Approach to Liver Transplantation for Perihilar Cholangiocarcinoma.Nadine Soliman, Ashton A Connor, Ashish Saharia, Sudha Kodali, Ahmed Elaileh
Transplantation Direct. 2025-03-01 - Sorafenib as Adjuvant Therapy Post-Liver Transplant: A Single-center Experience.Hala Hassanain, Ashton A Connor, Elizabeth W Brombosz, Khush Patel, Ahmed Elaileh
Transplantation Direct. 2025-02-01
Other
- American Liver FoundationAl b. Sure!, Instagram
https://www.instagram.com/reel/DCzwW2Vvuse/?igsh=cGRtZG03NDM1djZl
11/30/2024 - Health Equity in Transplantation CoalitionAl b.Sure!
https://www.instagram.com/reel/C4A4iaNrlG5/?igsh=MXdoa3JxYmwyYjZnaA==
3/2/2024
Press Mentions
- Data and Safety Monitoring Board Approves LyGenesis's Phase 2a Clinical Trial to Continue and Dose Escalate in Novel Trial of Organ RegenerationMarch 4th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: